Datasets
-
EATRIS-Plus multi-omics data of a human reference cohort
In this reference study, blood samples of 125 healthy individuals were analyzed with a wide range of -omics technologies, resulting in the most comprehensive -omics profiling... -
ReLife study clinical data
Data on tumour characteristics, treatment, complications, recurrence(s), progression and mortality were collected from medical records by data managers of the Netherlands Cancer... -
Continuous Vital Parameters with Clinical Data of Patients Admitted to a...
Vital parameters measured with the VisiMobile (Sotera Wireless; San Diego, CA, USA) of inpatients at Radboudumc (Nijmegen, The Netherlands). The dataset records minute-by-minute... -
Tumor mutational landscape in individuals with CMMRD
Whole exome sequencing data from the tumors (n=16) of individuals with constitutional mismatch repair deficiency. Data was aligned to GRCh38. -
PRIDE Study pharmacy data
Details on prescription medication fills in the three months before the last menstrual period until 6 months after the estimated date of delivery. Necessitates additional... -
UroLife study food frequency questionnaire
A 163-item Food Frequency questionnaire was completed at 6 weeks (referring to pre-diagnosis lifestyle; n=1439)) and 3 (n=1316), 15 (n=1143) en 51 months (n<589) after... -
ReLife study blood samples
Serum and EDTA plasma samples were collected at 3 (n=335), 12 (n=266) and 24 months (n=237) after surgery. EDTA plasma samples have been analysed for CRP, IL-6, adiponectin, and... -
UroLife study quality of life questionnaire
The EORTC QLQ-C30 and EORTC QLQ-NMIBC24 was completed at 6 weeks (n=1451) and 3 (n=1334), 15 (n=1159) and 51 months (n=588) after diagnosis. -
PRIDE Study paternal questionnaire data
Questionnaire data focusing on paternal exposures the 3 months before conception. Completed by the biological father, <50% participation rate. -
PRIDE-BIOME project
Subproject among 116 PRIDE Study participants. Gut microbiome data for maternal samples collected at gestational weeks 20 and 34, and 2 months after the estimated date of... -
Nederlands RBD Cohort
Data van het Nederlands RBD cohort, inclusief klinische data, neuroimaging, biomaterialen en wearable data. -
UroLife study general questionnaire
Patients with non-muscle invasive bladder cancer (n=1512) completed paper-and-pencil or web-based questionnaires at 6 weeks (referring to pre-diagnosis lifestyle; n=1486) and 3... -
POM wearables
Wearable data of the Personalized Parkinson Project, including data obtained with a Verily watch. -
PRISMA Imaging data
The PRISMA imaging data consists of both processed and unprocessed screening mammograms (two views of each breast for each participant) obtained at study entry. -
X-omics iPSC data analysis workflow data and metadata files
Multi-omics dataset generated from induced pluripotent stem cells (iPSC) cultures, differentiated to neurons by Ngn2 transduction, for seven days. iPSCs were derived from three... -
TRACK-PD
Data van het TRACK-PD cohort, inclusief klinische data, 7T MRI, biomaterialen en wearable data. -
UroLife study molecular subtypes
Molecular subtype based on immunohistrochemistry performed on tissue microarrays is available for 389 T1 NMIBC tumours. -
PRIDE Study blood samples
First trimester blood samples (plasma, serum, whole blood) of ~1000 PRIDE Study participants, available for genetic and biochemical analyses. Stored at -80°C. -
ReLife study body composition data
CT-based assessment of body composition is available for n=349 patients. -
Personalized Parkinson Project (PPP)
Data van het Parkinson Op Maat cohort, inclusief klinische data, neuroimaging, biomaterialen en wearable data.